BBIO logo

BridgeBio Pharma, Inc. (BBIO) Cash From Investing

Annual CFI:

$60.78M+$6.75M(+12.49%)
December 31, 2024

Summary

  • As of today, BBIO annual cash from investing is $60.78 million, with the most recent change of +$6.75 million (+12.49%) on December 31, 2024.
  • During the last 3 years, BBIO annual cash from investing has risen by +$261.61 million (+130.27%).
  • BBIO annual cash from investing is now -86.59% below its all-time high of $453.15 million, reached on December 31, 2022.

Performance

BBIO Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOcash flow metrics

Quarterly CFI:

-$13.00M-$11.41M(-715.17%)
June 30, 2025

Summary

  • As of today, BBIO quarterly cash from investing is -$13.00 million, with the most recent change of -$11.41 million (-715.17%) on June 30, 2025.
  • Over the past year, BBIO quarterly cash from investing has dropped by -$16.04 million (-527.84%).
  • BBIO quarterly cash from investing is now -108.69% below its all-time high of $149.70 million, reached on June 30, 2022.

Performance

BBIO Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOcash flow metrics

TTM CFI:

$20.39M-$16.04M(-44.03%)
June 30, 2025

Summary

  • As of today, BBIO TTM cash from investing is $20.39 million, with the most recent change of -$16.04 million (-44.03%) on June 30, 2025.
  • Over the past year, BBIO TTM cash from investing has dropped by -$43.02 million (-67.84%).
  • BBIO TTM cash from investing is now -95.54% below its all-time high of $456.98 million, reached on September 30, 2022.

Performance

BBIO TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

BBIO Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+12.5%-527.8%-67.8%
3Y3 Years+130.3%-108.7%-94.5%
5Y5 Years+128.0%+89.9%+113.3%

BBIO Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-86.6%+130.3%-108.8%at low-95.5%at low
5Y5-Year-86.6%+128.0%-108.7%+95.4%-95.5%+105.5%
All-TimeAll-Time-86.6%+128.0%-108.7%+95.4%-95.5%+105.5%

BBIO Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$13.00M(-715.2%)
$20.39M(-44.0%)
Mar 2025
-
-$1.59M(+50.7%)
$36.43M(-40.1%)
Dec 2024
$60.78M(+12.5%)
-$3.24M(-108.5%)
$60.78M(-5.0%)
Sep 2024
-
$38.23M(+1157.8%)
$63.95M(+0.9%)
Jun 2024
-
$3.04M(-86.6%)
$63.41M(-1.7%)
Mar 2024
-
$22.75M(>+9900.0%)
$64.49M(+19.3%)
Dec 2023
$54.03M(-88.1%)
-$66.00K(-100.2%)
$54.03M(-25.0%)
Sep 2023
-
$37.68M(+814.8%)
$72.06M(-60.2%)
Jun 2023
-
$4.12M(-66.5%)
$181.24M(-44.5%)
Mar 2023
-
$12.30M(-31.5%)
$326.82M(-27.9%)
Dec 2022
$453.15M(+325.6%)
$17.96M(-87.8%)
$453.15M(-0.8%)
Sep 2022
-
$146.86M(-1.9%)
$456.98M(+23.8%)
Jun 2022
-
$149.70M(+8.0%)
$369.09M(+67.9%)
Mar 2022
-
$138.62M(+535.9%)
$219.85M(+209.5%)
Dec 2021
-$200.83M
$21.80M(-63.0%)
-$200.83M(-43.8%)
DateAnnualQuarterlyTTM
Sep 2021
-
$58.97M(>+9900.0%)
-$139.61M(+42.7%)
Jun 2021
-
$458.00K(+100.2%)
-$243.63M(+34.7%)
Mar 2021
-
-$282.05M(-439.7%)
-$373.07M(-604.0%)
Dec 2020
-$52.99M(+75.6%)
$83.02M(+284.3%)
-$52.99M(+65.3%)
Sep 2020
-
-$45.05M(+65.1%)
-$152.91M(+49.9%)
Jun 2020
-
-$128.98M(-439.2%)
-$305.20M(-72.6%)
Mar 2020
-
$38.02M(+325.0%)
-$176.80M(+18.6%)
Dec 2019
-$217.25M(-932.8%)
-$16.90M(+91.4%)
-$217.25M(-6.5%)
Sep 2019
-
-$197.34M(>-9900.0%)
-$203.95M(-2727.2%)
Jun 2019
-
-$583.00K(+76.0%)
-$7.21M(+12.9%)
Mar 2019
-
-$2.43M(+32.6%)
-$8.29M(+60.6%)
Dec 2018
-$21.04M(-4433.6%)
-$3.60M(-494.9%)
-$21.04M(-20.6%)
Sep 2018
-
-$605.00K(+63.4%)
-$17.44M(-3.6%)
Jun 2018
-
-$1.66M(+89.1%)
-$16.83M(-10.9%)
Mar 2018
-
-$15.18M
-$15.18M
Dec 2017
-$464.00K
-
-

FAQ

  • What is BridgeBio Pharma, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. annual cash from investing year-on-year change?
  • What is BridgeBio Pharma, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. quarterly cash from investing year-on-year change?
  • What is BridgeBio Pharma, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. TTM cash from investing year-on-year change?

What is BridgeBio Pharma, Inc. annual cash from investing?

The current annual cash from investing of BBIO is $60.78M

What is the all-time high annual cash from investing for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high annual cash from investing is $453.15M

What is BridgeBio Pharma, Inc. annual cash from investing year-on-year change?

Over the past year, BBIO annual cash from investing has changed by +$6.75M (+12.49%)

What is BridgeBio Pharma, Inc. quarterly cash from investing?

The current quarterly cash from investing of BBIO is -$13.00M

What is the all-time high quarterly cash from investing for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high quarterly cash from investing is $149.70M

What is BridgeBio Pharma, Inc. quarterly cash from investing year-on-year change?

Over the past year, BBIO quarterly cash from investing has changed by -$16.04M (-527.84%)

What is BridgeBio Pharma, Inc. TTM cash from investing?

The current TTM cash from investing of BBIO is $20.39M

What is the all-time high TTM cash from investing for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high TTM cash from investing is $456.98M

What is BridgeBio Pharma, Inc. TTM cash from investing year-on-year change?

Over the past year, BBIO TTM cash from investing has changed by -$43.02M (-67.84%)
On this page